Journey Medical Corp (DERM)
6.51
+0.26
(+4.08%)
USD |
NASDAQ |
Oct 04, 16:00
6.51
0.00 (0.00%)
After-Hours: 17:31
Journey Medical SG&A Expense (TTM): 37.22M for June 30, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 37.22M |
March 31, 2024 | 39.04M |
December 31, 2023 | 43.91M |
September 30, 2023 | 48.06M |
June 30, 2023 | 55.00M |
March 31, 2023 | 58.04M |
December 31, 2022 | 59.47M |
Date | Value |
---|---|
September 30, 2022 | 60.54M |
June 30, 2022 | 55.72M |
March 31, 2022 | 48.32M |
December 31, 2021 | 39.83M |
September 30, 2021 | 30.59M |
June 30, 2021 | 25.67M |
March 31, 2021 | 22.62M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
22.62M
Minimum
Mar 2021
60.54M
Maximum
Sep 2022
44.57M
Average
45.98M
Median
SG&A Expense (TTM) Benchmarks
Fortress Biotech Inc | 83.11M |
Checkpoint Therapeutics Inc | 8.797M |
Avenue Therapeutics Inc | 5.076M |
Eton Pharmaceuticals Inc | 19.66M |
4D Molecular Therapeutics Inc | 40.61M |